South Africa’s first clinical trial of a COVID-19 vaccine is entering its fourth week, with around 2000 volunteers participating. However, following the start of the trial, anti-vaccine protestors took to the streets to convey their concerns and sentiments with vaccine testing. Thabani Maphosa, Managing Director for Country Programmes at Gavi spoke to CNBC Africa for more.